Get the Stockscreener App
62.98
6.99%
4.115
Tempus Ai Inc Stock (TEM) Latest News
Will Ambry Genetics Acquisition Drive Tempus AI's Prospects? - MSN
Tempus AI CEO to Present at Piper Sandler Healthcare Conference in December | TEM Stock News - StockTitan
Tempus to Participate in the Piper Sandler 36th Annual Healthcare Conference - Business Wire
Medtronic, Tempus testing AI to find potential TAVR patients - Yahoo Finance
Tempus AI (NASDAQ:TEM) Trading Up 7.6%Should You Buy? - MarketBeat
Gene Panel Market to Surpass USD 11.75 Billion by 2031 | SkyQuest Technology - GlobeNewswire Inc.
Cathie Wood's ARK buys Tempus AI stock, sells Exact Sciences By Investing.com - Investing.com Canada
Cathie Wood's ARK buys Tempus AI stock, sells Exact Sciences - Investing.com India
Items Tagged with 'Tempus AI Inc.' - BioWorld Online
Medtronic, Tempus ALERT to disparities in valve replacement - BioWorld Online
Tempus AI stock jumps 14% following $411M IPO - MSN
Tempus Stock Declines Despite Q3 Earnings & Revenues Beat Estimates - MSN
Tempus AI, Inc. (NASDAQ:TEM) Q3 2024 Earnings Call Transcript - MSN
Tempus AI downgraded to hold by Stifel, valuation cited - MSN
Cathie Wood's ARK ETFs Adjust Portfolio with Notable Tesla and Tempus AI Stock Trades - Investing.com Nigeria
Tempus AI, Inc agreed to acquire Ambry Genetics Corporation from REALM IDx, Inc. for approximately $600 million. - Marketscreener.com
Short Interest in Tempus AI, Inc. (NASDAQ:TEM) Rises By 19.2% - MarketBeat
Behind the Scenes of Tempus AI's Latest Options Trends - Benzinga
Sumitomo Mitsui Trust Group Inc. Buys 1,145,698 Shares of Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
AI Health Care Co. Can't Sink Ex-Worker's Sex Bias Claims - Law360
U.S. Indexes Dropped Thursday; Tempus AI Took Biggest Hit - Barron's
Sigma Planning Corp Acquires Shares of 23,369 Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
Piper Sandler raises Tempus AI stock target by 75%, keeps Neutral rating after earnings - Investing.com
Tempus AI: Pioneering the Future of Precision Medicine Through AI-Driven Innovation (TEM) - Seeking Alpha
U.S. Indexes Declined Tuesday; Tempus AI Fell Furthest - Barron's
Tempus AI's (TEM) "Neutral" Rating Reaffirmed at Piper Sandler - MarketBeat
Tempus AI (NASDAQ:TEM) Sets New 12-Month HighHere's What Happened - MarketBeat
Tempus Partners with Flatiron Health, Brings Genomic Testing to 800+ Cancer Centers | TEM Stock News - StockTitan
Stifel cuts Tempus AI stock to Hold, lifts PT on Ambry Genetics deal - Investing.com Australia
Tempus AI (NASDAQ:TEM) Shares Gap DownHere's Why - MarketBeat
Tempus Announces Nine Abstracts Accepted for Presentation at the 2024 Society for Immunotherapy of Cancer Annual Meeting - Marketscreener.com
Tempus Publishes Study Highlighting Benefits of Concurrent RNA and DNA Sequencing in Advanced Cancer Care - Business Wire
Tempus AI (NASDAQ:TEM) Cut to "Hold" at Stifel Nicolaus - MarketBeat
Tempus AI, Inc. (NASDAQ:TEM) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Tempus AI to Buy Ambry Genetics for $600M - Orange County Business Journal
ARK Investment Management LLC Raises Holdings in Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
Tempus AI Inc (NASDAQ:TEM) Continues Strong Growth with 33% Revenue Increase, Price Target Raised to $56 - Insider Monkey
Tempus Announces the Clinical Launch of its Immune Profile Score Algorithmic Test - 01Net
10 AI News You Shouldn’t Miss - Insider Monkey
Exciting Growth Potential Ahead for Tempus AI (TEM) - Insider Monkey
Tempus AI’s $600 Million Acquisition of Ambry Genetics - Global Legal Chronicle
Tempus AI to buy genetic testing company for $600M - MedTech Dive
Ambry Genetics Being Acquired by Tempus AI for $600M - Orange County Business Journal
Tempus AI (NASDAQ:TEM) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Needham raises Tempus AI stock target on Q3 results, acquisition By Investing.com - Investing.com Australia
Needham raises Tempus AI stock target on Q3 results, acquisition - Investing.com India
Tempus: Q3 Earnings Snapshot - The Advocate
0.28%
1.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):